Bioactive compound-enhanced tomatoes for metabolic health
Innovative tomatoes enriched with bioactive compounds to combat metabolic syndrome and obesity without changing dietary habits. These tomatoes maintain high metabolite levels across growing conditions and show potential in improving lipid profiles and reducing fat in studies.
Overview
This innovation introduces a new variety of tomatoes that are enriched with bioactive compounds known to offer health benefits, specifically targeting metabolic syndrome and obesity. These enhanced tomatoes allow consumers to gain health advantages without altering their eating habits. The bioactive compounds have been linked to improved lipid profiles and reduced fat accumulation, addressing a significant global health issue.
Technical specifications
Key features:
- Enrichment of tomatoes with bioactive compounds not naturally found in cultivated tomatoes
- Consistent maintenance of high metabolite levels across various growing conditions and industrial processing
- Potential nutraceutical benefits demonstrated in laboratory rats, showing reduced abdominal fat and improved lipid profiles
Research methodology:
- Use of SPET™ technology for genotyping and genome-wide association analysis to identify genetic determinants of metabolite accumulation
- Crossbreeding with commercial cultivars to evaluate gene expression and metabolite levels
- CRISPR/Cas9 gene editing to validate and enhance bioactive compound accumulation
Technology readiness level
This technology is currently at TRL 5, having been validated in a relevant environment. Further development and validation are ongoing to advance its readiness for commercial application.
About Instituto de Biología Molecular y Celular de Rosario
IBR is a public research institute jointly operated by CONICET and the National University of Rosario, with more than 240 researchers, staff, and trainees across two sites: the CONICET CCT‑Rosario campus and a facility within UNR’s Faculty of Biochemical and Pharmaceutical Sciences. For industry, the institute offers co‑located laboratories, shared instrumentation, BSL‑2/3 suites, an NMR annex, and open service platforms run by expert staff; these resources are used by more than 40 SMEs and large companies. Startup formation is supported by Bio.R, an on‑site accelerator and incubation space adjacent to the main building, complemented by a dedicated foundation that promotes transfer to the productive sector. Research is principally supported by Argentina’s national science system through CONICET and competitive programs, with international collaborations that comply with NIH Financial Conflict of Interest guidelines.
delivered to your inbox.